x
African Health Sciences

    Book Now

    • 256(41)530021
    • info@africanhealthsciences.org
    African Health Sciences
    • info@africanhealthsciences.org
    • Give Feedback
    • Home
    • About Us
    • Staff
    • Focus & Scope
    • For Authors
    • More Links
      • About The Journal
      • Latest Articles
      • Journal Archives
      • Our Events
      • Faq’s
    • Contact Us
    Logo

    Contact Info

    • P. O. Box 7072 Kampala, Uganda
    • +256(41)530021
    • info@africanhealthsciences.org
    • ISSN 1680-6905
    • <!--
    • -->

    17Nov2017

    Potential drug-drug interactions on in-patient

    by admin,  0 Comments

    Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: prevalence, clinical importance and associated factors

    SJ Lubinga, E Uwiduhaye

    Abstract

    Background: Drug-drug interactions (DDIs) are an important cause of adverse drug reactions. The pharmacoepidemiology of such interactions in hospitals in Uganda is not known.

    Objectives: To determine the prevalence, clinical importance and factors associated with potential DDIs at Mbarara Regional Referral Hospital (MRRH), western Uganda. Methods: Retrospective analysis of 235 randomly selected hospitalization episodes (medication charts and medical notes) from MRRH over a 1-year period from January to December 2008. We collected data on demographics, medications, principal diagnosis, co-morbid conditions and the length of hospital stay. Epocrates Rx® was used to identify and classify potential DDIs according to mechanism and management strategy. Descriptive statistics were generated and logistic regression used to determine associated factors.

    Results: Overall prevalence of potential DDIs was approximately 23% (54 medication charts with at least one potential DDI out of 235 hospitalization episodes). Majority were postulated to occur through a pharmacodynamic mechanism (10.6%) and most required either “use with caution” (11.9%) or “modify treatment/monitor” (10.6%) as a suggested management strategy. After adjusting for confounders: age, sex, hospital department and number of co-morbid conditions, a principal diagnosis of a cardiovascular disease (OR 6.52 95% CI 1.32-32.14) and having 4 or more medicines on the chart (OR 4.30 95% CI 1.98-9.34) were associated with the presence of a potential DDI. Conclusion: Potential DDIs frequently occur at MRRH although most are not clinically significant. Patients with cardiovascular diseases and those who are prescribed multiple medications need to be monitored more closely.

    Keywords: drug-drug interactions, pharmacoepidemiology, prevalence, chart review

     

    Related posts:

    Review of the practice of traditional bone setting in Nigeria

    Hepatitis B virus and HIV infection among patients

    commercially available quinine sulphate tablets

    Recent Posts

    • Editor’s choice: Tackling infectious diseases, NCDs and sexual reproductivehealth issues as we enter our 24th year of remarkable growth
    • Preconception and contraceptive care for women living with HIV/AIDSattending antiretroviral treatment clinics in Lagos State, Nigeria
    • Effects of SNPs on TNF-α and IL-10 cytokine expression in TB and HIVpatients in the Capricorn district, Limpopo Province, South Africa
    • Prevalence of Schistosomiasis in a neglected community, South western Nigeria at two points in time, spaced three years apart
    • Review of Leishmaniasis in the Middle East and North Africa

    Recent Comments

    No comments to show.

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Categories

    • 2001 Issues
    • 2002 Issues
    • 2003 Issues
    • 2004 Issues
    • 2005 Issues
    • 2006 Issues
    • 2007 Issues
    • 2008 Issues
    • 2009 Issues
    • 2010 Issues
    • 2011 Issues
    • 2012 Issues
    • 2013 Issues
    • 2014 Issues
    • 2015 Issues
    • 2016 Issues
    • 2017 Issues
    • 2018 Issues
    • 2019 Issues
    • 2024 Issues
    • Articles
    • December issue
    • December Release
    • June Issue
    • June Release
    • March Issue
    • March Issue
    • March Release
    • News
    • number / volume 2
    • number /volume 1
    • number /volume 1
    • number /volume 1 2008
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 1
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2
    • number 2 special Issue
    • number 2 special Issue 2
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 3
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number 4
    • number/ volume 3 2008
    • number/ volume 4 2008
    • number/volume 1
    • number/volume 1
    • number/volume 2
    • number/volume 2
    • number/volume 2 2008
    • number/volume 3
    • number/volume 3
    • number/volume 3
    • number/volume 4
    • number/volume1
    • September Issue
    • September Release
    • Special Edition
    • special Issue
    • Uncategorized
    • Vol. 24 No. 1 (2024)
    • volume 1
    • volume 1
    • volume 1
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 2
    • volume 3
    • volume 3
    • volume 3
    • volume 3
    • volume 4
    • volume 4
    • volume 4
    • volume 4
    • volume1

    Archives

    • April 2024
    • May 2019
    • April 2019
    • September 2018
    • August 2018
    • January 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017

    Tags

    Achives Latest News


    ISSN 1680-6905

    • P. O. Box 7072 ,Kampala, Uganda
    • Call Us: 256(41)530021
    • info@africanhealthsciences.org

    Latest Activities

    Usefull Link

    • About AHS
    • Services
    • Focus & Scope
    • Our Articles
    • Contact Us

    Subscribe

    For research updates from African Health Sciences, sign up now!

      African Health Sciences © All Right Reserved